“””Ionis Pharmaceuticals, Inc. is a leading biotech firm specializing in RNA-targeted medicines within the United States. With a dedication to innovation and a focus on developing groundbreaking treatments, Ionis is making a profound impact on the biotech landscape. Their expansive portfolio includes pioneering treatments like TRYNGOLZA for familial chylomicronemia syndrome, WAINUA for hereditary transthyretin-mediated amyloidosis, […]
Tag: Biogen
Biogen’s Zurzuvae Strategy Shifts with OB/GYNs on Front Lines
“The shift in Biogen’s strategy concerning Zurzuvae, a drug marketed for postpartum depression, is significantly influenced by the increasingly pivotal role of obstetricians and gynecologists (OB/GYNs) in managing intricate pregnancy-related conditions. This change in strategy was not immediately apparent; initially, Biogen targeted psychiatrists as the primary audience for promoting Zurzuvae. However, the reality of postpartum […]
